People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TP Therapeutics, Inc. | — | Pharmaceuticals | Series C | $126.4M | $2.8B | 2018 |
Carl Maria Gordon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl Maria Gordon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BIHUA CHEN | 1 | 14 |
| George Lee | 1 | 6 |
| Yishan Li | 1 | 4 |
| Lewis J. Shuster | 1 | 4 |
| Kenneth Fong | 1 | 3 |
| Brett J. Zbar | 1 | 1 |
| Athena Maria Countouriotis | 1 | 1 |
| Sheila K. Gujrathi | 1 | 1 |
| Jingrong Cui | 1 | 1 |
| Robert J. Adelman | 1 | 1 |
| Hongbo Maria Lu | 1 | 1 |
| Simeon Maria George | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.